Industry and Geographic Information

3 Months Ended

Mar. 31, 2019

Industry And Geographic Information [Abstract]

The Company operates in one reportable segment. Sales to customers outside the U.S. represented $41.5 million (28%) and $41.9 million (25%) of total revenue for the three months ended March 31, 2019 and 2018, respectively. As of March 31, 2019 and December 31, 2018, accounts receivable due from foreign customers were $23.1 million and $23.4 million, respectively.

The Company had sales to individual customers in excess of 10% of total revenues, as follows:



	Three months ended March 31,
	2019		2018
Customer:
A	17	%	16	%
B	17	%	20	%
C	13	%	13	%
	47	%	49	%

As of March 31, 2019 and December 31, 2018, accounts receivable from customers with balances due in excess of 10% of total accounts receivable totaled $37.6 million and $33.3 million, respectively.

Consolidated net revenues by product category for the three months ended March 31, 2019 and 2018 are as follows (in thousands):



	Three months ended March 31,
	2019		2018
Rapid Immunoassay	$	62,494	$	80,685
Cardiac Immunoassay	65,872		68,444
Specialized Diagnostic Solutions	13,854		14,871
Molecular Diagnostic Solutions	5,748		5,143
Total revenues	$	147,968	$	169,143